NASDAQ: CABA
Cabaletta Bio Inc Stock Ownership - Who owns Cabaletta Bio?

Insider buying vs selling

Have Cabaletta Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CABA insiders and whales buy or sell their stock.

CABA Shareholders

What type of owners hold Cabaletta Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc7.82%3,970,026$6.91MInstitution
Adage Capital Partners GP LLC7.16%3,634,473$6.32MInstitution
Blackrock Inc6.80%3,452,147$6.01MInstitution
Vanguard Group Inc5.61%2,844,239$4.95MInstitution
Bain Capital Life Sciences Investors LLC5.44%2,760,888$4.80MInstitution
Jennison Associates LLC4.80%2,433,728$4.23MInstitution
Morgan Stanley3.37%1,708,888$2.97MInstitution
Schonfeld Strategic Advisors LLC3.28%1,662,401$2.89MInstitution
James E. Flynn3.21%1,628,506$2.83MInsider
Cantor Fitzgerald L P2.93%1,484,585$2.58MInstitution

1 of 3

CABA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CABA71.55%8.32%
VERU32.31%33.57%Net Buying
IVVD43.45%56.55%Net Selling
NTRB3.01%50.83%
NTHI0.31%91.78%Net BuyingNet Buying

Cabaletta Bio Stock Ownership FAQ

Who owns Cabaletta Bio?

Cabaletta Bio (NASDAQ: CABA) is owned by 71.55% institutional shareholders, 8.32% Cabaletta Bio insiders, and 20.13% retail investors. James E. Flynn is the largest individual Cabaletta Bio shareholder, owning 1.63M shares representing 3.21% of the company. James E. Flynn's Cabaletta Bio shares are currently valued at $2.83M.

If you're new to stock investing, here's how to buy Cabaletta Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.